YuBaiMD

Pathology • Houston, TX

Blood Banking & Transfusion Medicine, Molecular Genetics, Transplantation Immunology, Clinical Pathology

Assistant Professor, Pathology & Laboratory Medicine, University of Texas

Join to view full profile

Are you Dr. Bai?

Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.

Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Claim this profile

Not you? Find your profile

Office
6411 Fannin St
Houston, TX 77030
Phone+1 713-500-5300

Fax+1 713-500-0730

Summary

Dr. Yu Bai, MD is a board certified pathologist in Houston, Texas. She is currently licensed to practice medicine in Texas, Virginia, and Virginia. She is an Assistant Professor at University of Texas.

Education & Training

Beijing Medical UniversityClass of 1987

Certifications & Licensure

VA State Medical License 1998 - 2026
VA State Medical License 2005 - 2026
TX State Medical License 2005 - 2025
American Board of Pathology Clinical Pathology
American Board of Pathology Blood Banking/Transfusion Medicine
American Board of Pathology Pathology - Molecular Genetic

Publications & Presentations

PubMed

Impact of Massive Transfusion Activation on Time to Delivery of the First Cooler and Patient Survival: A Study of 4,313 Consecutive Activations.
Jan-Michael Van Gent, Devi Bavishi, Thomas W Clements, James B Dickey, Rhonda Hobbs
Journal of the American College of Surgeons. 2025-04-01
METTL3-Mediated m6A Methylation Stabilizes IFI27 to Drive Esophageal Squamous Cell Carcinoma Progression Through an IGF2BP2-Dependent Mechanism.
Xinhua Zhang, Yu Bai, Linlin Shang, Yinghao Wang, Wenjian Yao
Journal of Biochemical and Molecular Toxicology. 2025-03-01
DNMT1-driven methylation of RORA facilitates esophageal squamous cell carcinoma progression under hypoxia through SLC2A3.
Wenjian Yao, Linlin Shang, Yinghao Wang, Lei Xu, Yu Bai
Journal of Translational Medicine. 2024-12-31

Press Mentions

Impact of 9-Minute Withdrawal Time on the Adenoma Detection Rate: A Multicenter Randomized Controlled TrialNovember 18th, 2020
Prevalence of Gastric Cancer Precursors in Gastroscopy-Screened Adults by Family History of Gastric Cancer and of Cancers Other Than GastricNovember 16th, 2020
Dizal Highlights Its Advances in Hematological Portfolio at 2023 ASH, Featuring Breakthroughs in Lymphoma TreatmentNovember 4th, 2023
Join now to see all